216 related articles for article (PubMed ID: 33870230)
1. Protocol for establishing organoids from human ovarian cancer biopsies.
Maenhoudt N; Vankelecom H
STAR Protoc; 2021 Jun; 2(2):100429. PubMed ID: 33870230
[TBL] [Abstract][Full Text] [Related]
2. Developing Organoids from Ovarian Cancer as Experimental and Preclinical Models.
Maenhoudt N; Defraye C; Boretto M; Jan Z; Heremans R; Boeckx B; Hermans F; Arijs I; Cox B; Van Nieuwenhuysen E; Vergote I; Van Rompuy AS; Lambrechts D; Timmerman D; Vankelecom H
Stem Cell Reports; 2020 Apr; 14(4):717-729. PubMed ID: 32243841
[TBL] [Abstract][Full Text] [Related]
3. An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity.
Kopper O; de Witte CJ; Lõhmussaar K; Valle-Inclan JE; Hami N; Kester L; Balgobind AV; Korving J; Proost N; Begthel H; van Wijk LM; Revilla SA; Theeuwsen R; van de Ven M; van Roosmalen MJ; Ponsioen B; Ho VWH; Neel BG; Bosse T; Gaarenstroom KN; Vrieling H; Vreeswijk MPG; van Diest PJ; Witteveen PO; Jonges T; Bos JL; van Oudenaarden A; Zweemer RP; Snippert HJG; Kloosterman WP; Clevers H
Nat Med; 2019 May; 25(5):838-849. PubMed ID: 31011202
[TBL] [Abstract][Full Text] [Related]
4. Preserved genetic diversity in organoids cultured from biopsies of human colorectal cancer metastases.
Weeber F; van de Wetering M; Hoogstraat M; Dijkstra KK; Krijgsman O; Kuilman T; Gadellaa-van Hooijdonk CG; van der Velden DL; Peeper DS; Cuppen EP; Vries RG; Clevers H; Voest EE
Proc Natl Acad Sci U S A; 2015 Oct; 112(43):13308-11. PubMed ID: 26460009
[TBL] [Abstract][Full Text] [Related]
5. Generation of Pancreatic Organoid-Derived Isografts.
D'Agosto S; Lupo F; Corbo V
STAR Protoc; 2020 Sep; 1(2):100047. PubMed ID: 33111093
[TBL] [Abstract][Full Text] [Related]
6. Patient-derived organoids in ovarian cancer: Current research and its clinical relevance.
Kumar S; Raina M; Tankay K; Ingle GM
Biochem Pharmacol; 2023 Jul; 213():115589. PubMed ID: 37196684
[TBL] [Abstract][Full Text] [Related]
7. Establishment and Long-Term Culture of Organoids Derived from Human Biliary Tract Carcinoma.
Saito Y; Muramatsu T; Saito H
STAR Protoc; 2020 Jun; 1(1):100009. PubMed ID: 33111070
[TBL] [Abstract][Full Text] [Related]
8. Organoids in ovarian cancer: a platform for disease modeling, precision medicine, and drug assessment.
Hu H; Sun C; Chen J; Li Z
J Cancer Res Clin Oncol; 2024 Mar; 150(3):146. PubMed ID: 38509422
[TBL] [Abstract][Full Text] [Related]
9. Protocol for derivation of organoids and patient-derived orthotopic xenografts from glioma patient tumors.
Oudin A; Baus V; Barthelemy V; Fabian C; Klein E; Dieterle M; Wantz M; Hau AC; Dording C; Bernard A; Michelucci A; Yabo YA; Kanli G; Keunen O; Bjerkvig R; Niclou SP; Golebiewska A
STAR Protoc; 2021 Jun; 2(2):100534. PubMed ID: 34027491
[TBL] [Abstract][Full Text] [Related]
10. Murine cochlear cell sorting and cell-type-specific organoid culture.
Kubota M; Heller S
STAR Protoc; 2021 Sep; 2(3):100645. PubMed ID: 34278332
[TBL] [Abstract][Full Text] [Related]
11. High-throughput drug screening of fine-needle aspiration-derived cancer organoids.
Bergdorf K; Phifer C; Bharti V; Westover D; Bauer J; Vilgelm A; Lee E; Weiss V
STAR Protoc; 2020 Dec; 1(3):100212. PubMed ID: 33377106
[TBL] [Abstract][Full Text] [Related]
12. A platform for efficient establishment and drug-response profiling of high-grade serous ovarian cancer organoids.
Senkowski W; Gall-Mas L; Falco MM; Li Y; Lavikka K; Kriegbaum MC; Oikkonen J; Bulanova D; Pietras EJ; Voßgröne K; Chen YJ; Erkan EP; Dai J; Lundgren A; Grønning Høg MK; Larsen IM; Lamminen T; Kaipio K; Huvila J; Virtanen A; Engelholm L; Christiansen P; Santoni-Rugiu E; Huhtinen K; Carpén O; Hynninen J; Hautaniemi S; Vähärautio A; Wennerberg K
Dev Cell; 2023 Jun; 58(12):1106-1121.e7. PubMed ID: 37148882
[TBL] [Abstract][Full Text] [Related]
13. A robust protocol for the generation of human midbrain organoids.
Zagare A; Gobin M; Monzel AS; Schwamborn JC
STAR Protoc; 2021 Jun; 2(2):100524. PubMed ID: 34027482
[TBL] [Abstract][Full Text] [Related]
14. Patient-derived ovarian cancer organoids capture the genomic profiles of primary tumours applicable for drug sensitivity and resistance testing.
Nanki Y; Chiyoda T; Hirasawa A; Ookubo A; Itoh M; Ueno M; Akahane T; Kameyama K; Yamagami W; Kataoka F; Aoki D
Sci Rep; 2020 Jul; 10(1):12581. PubMed ID: 32724113
[TBL] [Abstract][Full Text] [Related]
15. Protocol for generation of lung adenocarcinoma organoids from clinical samples.
Li Z; Yu L; Chen D; Meng Z; Chen W; Huang W
STAR Protoc; 2021 Mar; 2(1):100239. PubMed ID: 33426535
[TBL] [Abstract][Full Text] [Related]
16. Protocol for Large-Scale Production of Kidney Organoids from Human Pluripotent Stem Cells.
Sander V; Przepiorski A; Crunk AE; Hukriede NA; Holm TM; Davidson AJ
STAR Protoc; 2020 Dec; 1(3):100150. PubMed ID: 33377044
[TBL] [Abstract][Full Text] [Related]
17. Patient-Derived Ovarian Cancer Organoids Mimic Clinical Response and Exhibit Heterogeneous Inter- and Intrapatient Drug Responses.
de Witte CJ; Espejo Valle-Inclan J; Hami N; Lõhmussaar K; Kopper O; Vreuls CPH; Jonges GN; van Diest P; Nguyen L; Clevers H; Kloosterman WP; Cuppen E; Snippert HJG; Zweemer RP; Witteveen PO; Stelloo E
Cell Rep; 2020 Jun; 31(11):107762. PubMed ID: 32553164
[TBL] [Abstract][Full Text] [Related]
18. Stem cell-derived organoids and their application for medical research and patient treatment.
Bartfeld S; Clevers H
J Mol Med (Berl); 2017 Jul; 95(7):729-738. PubMed ID: 28391362
[TBL] [Abstract][Full Text] [Related]
19. Establishment of patient-derived cancer organoids for drug-screening applications.
Driehuis E; Kretzschmar K; Clevers H
Nat Protoc; 2020 Oct; 15(10):3380-3409. PubMed ID: 32929210
[TBL] [Abstract][Full Text] [Related]
20. An experimental model for ovarian cancer: propagation of ovarian cancer initiating cells and generation of ovarian cancer organoids.
Chen YA; Lu CY; Cheng WF; Kuo KT; Yu CW; Ho HN; Chen HF; Pan SH
BMC Cancer; 2022 Sep; 22(1):967. PubMed ID: 36085021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]